Finance

South Africa’s potential kingmakers struggle with white image By Reuters

By Joe Bavier and Wendell Roelf CAPE TOWN (Reuters) - Looking out of his window at Cape Town's False Bay, Nick Searra...

Ruling ANC loses majority in parliament

Voters during the South Africa General Elections on May 29, 2024 in Johannesburg, South Africa. Gallo Images | Gallo Images | Getty ImagesSouth Africa's...

7 key mantras for young traders of Dalal Street to master the art of options trading – Trading Tips

Jun 02, 2024, 09:57:46 AM ISTTrading can be a highly rewarding profession, but it is imperative to acknowledge that it is not a...

China’s Dong Jun warns Taiwan separatist forces face ‘self-destruction’

China's Defense Minister Dong Jun speaks during the 21st Shangri-La Dialogue summit in Singapore on June 2, 2024.Nhac Nguyen | AFP | Getty...

Live from ASCO 2024 | Ascentage Pharma Releases Updated Data of FAK/ALK/ROS1 Inhibitor APG-2449 in Patients with NSCLC By Investing.com

SUZHOU, China, and ROCKVILLE, Md., June 1, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for...

North Korea sends 600 more trash balloons over border, South says By Reuters

SEOUL (Reuters) - North Korea sent some 600 balloons carrying trash into South Korea overnight, Seoul said on Sunday, in Pyongyang's latest...

Innovent Presents Phase 1 Clinical Data of First-in-class PD-1/IL-2α Bispecific Antibody Fusion Protein (IBI363) in Melanoma, Colorectal Cancer and other Solid Tumors at the...

SAN FRANCISCO, U.S. and SUZHOU, China, June 1, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops,...

Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Biogen Inc. and Encourages Investors to Contact the...

NEW YORK, June 01, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, reminds investors that...

Innovent Announces Data from Pivotal Phase 2 TRUST-I Study of Taletrectinib（ROS1 Inhibitor) are Published in the JCO and Reported at 2024 ASCO Annual Meeting

SAN FRANCISCO, U.S. and SUZHOU, China, June 1, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops,...
1...6,3326,3336,334...6,519Page 6,333 of 6,519

Latest articles

spot_imgspot_img